Do Cardiac Health: Advanced New Generation Ecosystem - Phase 2
Do CHANGE-2
1 other identifier
interventional
250
2 countries
2
Brief Summary
The Do CHANGE service is designed for cardiac patients who could benefit from lifestyle change and a better disease management. The study aims to support patients with behavior change by providing them with devices and behavioral intervention in order to facilitate long-term behavior change.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cardiovascular-diseases
Started Jul 2017
Shorter than P25 for not_applicable cardiovascular-diseases
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2017
CompletedFirst Posted
Study publicly available on registry
June 6, 2017
CompletedStudy Start
First participant enrolled
July 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2018
CompletedJuly 26, 2018
July 1, 2018
1 year
May 31, 2017
July 25, 2018
Conditions
Outcome Measures
Primary Outcomes (3)
Lifestyle
Lifestyle change will be measured with the HPLP-II questionnaire which assesses multiple domains of lifestyle. This will make it possible to compare the two groups.
3 months
Quality of Life (QoL)
Quality of life will be assessed with the WHOQoL-Bref which is a validated questionnaire and taps into different domains of quality of life.
3 months
Behavioral flexibility
With the Do Something Different purpose designed questionnaire changes in behavioral flexibility will be measured. This programme has previously shown to be effective in changing lifestyle behaviors among physically healthy subjects.
3 months
Secondary Outcomes (3)
Satisfaction, usability, and acceptance of the intervention
6 months
Cost effectiveness
6 months
Health care utilization
6 months
Other Outcomes (2)
Identification of Subgroups that benefit
6 months
Effects of intervention on physiological data
6 months
Study Arms (2)
Intervention
EXPERIMENTALBesides the behavior change programme (Do Something Different) 1. All patients will receive: Fitbit, Beddit, Care-portal, Do CHANGE app (including dietary habits picture taking), CookiT (smart spatula that monitors cooking behavior) 2. patients with heart failure will, in addition to the above mentioned, be offered a weight scale, blood pressure monitor, and FluiT (smart cup to measure fluid intake). 3. Patients with hypertension will also be offered a bloodpressure monitor. Data from these devices will be gathered and visible for patients (in patient portal) and for their health care provider (health care provider portal). In case of negative results the patient will be contacted by their health care provider (usually the cardiologist). Once every week the patients will be contacted to discuss their progress and will be given feedback about their dietary intake.
Care as usual
NO INTERVENTIONPatients in this arm will receive care as usual with no restrictions.
Interventions
Besides the behavior change programme (Do Something Different) 1. All patients will receive: Fitbit, Beddit, Care-portal, Do CHANGE app (including dietary habits picture taking), CookiT (smart spatula that monitors cooking behavior) 2. patients with heart failure will, in addition to the above mentioned, be offered a weight scale, blood pressure monitor, and FluiT (smart cup to measure fluid intake). 3. Patients with hypertension will also be offered a bloodpressure monitor. Data from these devices will be gathered and visible for patients (in patient portal) and for their health care provider (health care provider portal). In case of negative results the patient will be contacted by their health care provider (usually the cardiologist). Once every week the patients will be contacted to discuss their progress and will be given feedback about their dietary intake.
Eligibility Criteria
You may qualify if:
- age 18-75 years
- diagnosed with CAD, HF or HT
- having at least two of the following risk factors: smoking, positive family history, increased cholesterol, diabetes, sedentary lifestyle, psychosocial risk factors.
- Patients should also have access to the Internet and have a smartphone (and sufficient knowledge on using personal computer or smartphone)
- sufficient knowledge of the countries' native language.
You may not qualify if:
- significant cognitive impairments (e.g. dementia)
- patients who are on the waiting list for heart transplantation
- life expectancy \<1 year
- life threatening comorbidities (e.g. cancers),
- a history of psychiatric illness other than anxiety/depression
- patients who do not have access to internet
- patients with insufficient knowledge of the local pilot language (Dutch, Chinese and Catalonian).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Elisabeth-TweeSteden Ziekenhuislead
- European Commissioncollaborator
- Badalona Serveis Assistencialscollaborator
- Smart Homescollaborator
- ONMIcollaborator
- Eindhoven University of Technologycollaborator
- Docobo Ltd.collaborator
- Do Something Differentcollaborator
- Buddhist Tzu Chi General Hospitalcollaborator
- The Industrial Technology Research Institutecollaborator
Study Sites (2)
Badalona Serveis Assisstencials
Badalona, Barcelona, 08911, Spain
Buddhist Tzu Chi Dalin general hospital
Dalin, 62247, Taiwan
Related Publications (7)
Roovers T, Habibovic M, Lodder P, Widdershoven JW, Kop WJ. Changes in heart rate variability during an eHealth behavior change intervention program in patients with cardiovascular disease. Int J Cardiol Heart Vasc. 2024 Nov 22;55:101563. doi: 10.1016/j.ijcha.2024.101563. eCollection 2024 Dec.
PMID: 39649024DERIVEDHabibovic M, Piera-Jimenez J, Wetzels M, Widdershoven JWGM, Soedamah-Muthu SS. Associations between behavioral flexibility and health behavior in cardiac patients in the Do CHANGE trials. Health Psychol. 2022 Oct;41(10):710-718. doi: 10.1037/hea0001151. Epub 2022 May 16.
PMID: 35575702DERIVEDPiera-Jimenez J, Winters M, Broers E, Valero-Bover D, Habibovic M, Widdershoven JWMG, Folkvord F, Lupianez-Villanueva F. Changing the Health Behavior of Patients With Cardiovascular Disease Through an Electronic Health Intervention in Three Different Countries: Cost-Effectiveness Study in the Do Cardiac Health: Advanced New Generation Ecosystem (Do CHANGE) 2 Randomized Controlled Trial. J Med Internet Res. 2020 Jul 28;22(7):e17351. doi: 10.2196/17351.
PMID: 32720908DERIVEDHabibovic M, Gavidia G, Broers E, Wetzels M, Ayoola I, Ribas V, Piera-Jimenez J, Widdershoven J, Denollet J. Type D personality and global positioning system tracked social behavior in patients with cardiovascular disease. Health Psychol. 2020 Aug;39(8):711-720. doi: 10.1037/hea0000823. Epub 2020 Apr 16.
PMID: 32297772DERIVEDBroers ER, Widdershoven J, Denollet J, Lodder P, Kop WJ, Wetzels M, Ayoola I, Piera-Jimenez J, Habibovic M; Do CHANGE Consortium. Personalized eHealth Program for Life-style Change: Results From the "Do Cardiac Health Advanced New Generated Ecosystem (Do CHANGE 2)" Randomized Controlled Trial. Psychosom Med. 2020 May;82(4):409-419. doi: 10.1097/PSY.0000000000000802.
PMID: 32176191DERIVEDBroers ER, Gavidia G, Wetzels M, Ribas V, Ayoola I, Piera-Jimenez J, Widdershoven JWMG, Habibovic M; Do CHANGE consortium. Usefulness of a Lifestyle Intervention in Patients With Cardiovascular Disease. Am J Cardiol. 2020 Feb 1;125(3):370-375. doi: 10.1016/j.amjcard.2019.10.041. Epub 2019 Nov 6.
PMID: 31761149DERIVEDHabibovic M, Broers E, Piera-Jimenez J, Wetzels M, Ayoola I, Denollet J, Widdershoven J. Enhancing Lifestyle Change in Cardiac Patients Through the Do CHANGE System ("Do Cardiac Health: Advanced New Generation Ecosystem"): Randomized Controlled Trial Protocol. JMIR Res Protoc. 2018 Feb 8;7(2):e40. doi: 10.2196/resprot.8406.
PMID: 29422454DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Jos Widdershoven, MD, PhD
Elisabeth-TweeSteden Ziekenhuis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
May 31, 2017
First Posted
June 6, 2017
Study Start
July 27, 2017
Primary Completion
July 31, 2018
Study Completion
July 31, 2018
Last Updated
July 26, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share